BioSpace News Archive

Business

Castle Creek Pharma Announces Hiring of Dr. Amir Tavakkol as Executive VP and Chief Development Officer

Castle Creek Pharma today announced that Amir Tavakkol, Ph.D., has joined the company as executive VP and chief development officer who will report directly to Michael Derby, co-founder and CEO at CCP.

October 30, 2017

·

2 min read

Pharm Country

Takeda and the New York Academy of Sciences Announce Innovators in Science Award Honorees

The Winner of the Senior Scientist Award is Shigetada Nakanishi, M.D., Ph.D., Director, Suntory Foundation for Life Sciences Bioorganic Research Institute in Japan.

October 30, 2017

·

6 min read

Drug Development

Syros Presents New Preclinical PK and PD Data for SY-1365, Its First-in-Class Selective CDK7 Inhibitor, at AACR-NCI-EORTC Conference

Syros Pharmaceuticals announced that new preclinical pharmacodynamic and pharmacokinetic data providing a rationale for the twice weekly dosing regimen currently being used in the ongoing Phase 1 clinical trial of SY-1365.

October 30, 2017

·

7 min read

Drug Development

CBT Pharma Presents Data Demonstrating Anti-Tumor Activity of its PD-L1 Immunotherapy Antibody, CBT-502 at the AACR-NCI-EORTC International Conference on Molecular Target and Cancer Therapeutics

CBT Pharma presented preclinical data which showed that CBT-502 efficiently inhibited binding of PD-L1 with no binding to PD-L2, CD28, ICOS or CTLA4.

October 30, 2017

·

3 min read

Drug Development

Eyenovia Publication of EYE 102 Phase II Results Demonstrates Strong Pharmacodynamic Effect, Tolerability and Reduced Systemic Exposure of High-Precision Micro-dosing compared to Conventional Eyedroppers

Eyenovia’s micro-dose delivery of topical phenylephrine achieves comparable dilation results with a dose one-quarter the volume of a conventional pipette eye dropper.

October 30, 2017

·

4 min read

Business

Arena to Release Third Quarter 2017 Financial Results and Provide Corporate Update on Tuesday, November 7

Arena, today announced that the Company will release its third quarter 2017 financial results and provide a corporate update on Tuesday, November 7, 2017, after the close of the U.S. financial markets.

October 30, 2017

·

2 min read

Business

Michael J. Fox Foundation and 23andMe Announce Collaboration to Capture Parkinson’s Experience at Scale and Amplify Patient Voice in Research and Care

The Michael J. Fox Foundation for Parkinson’s Research and 23andMe announced a collaboration to build a large, diverse cohort of both patients and control volunteers who have consented to participate in research.

October 30, 2017

·

6 min read

Business

Boehringer Ingelheim Expands Collaboration With Sarah Cannon Research Institute to Investigate Novel Immuno-Oncology Combination Therapy

Boehringer Ingelheim and Sarah Cannon Research Institute today announced an expansion of their strategic partnership which combines Boehringer Ingelheim’s oncology research and Sarah Cannon’s expertise in clinical trial design.

October 30, 2017

·

5 min read

Business

GRAMINEX Expands Its Partnership With IDIPharma After Clinical Study Publication.

IDIPharma and Graminex have agreed to expand clinical research on Graminex Flower Pollen Extract.

October 30, 2017

·

2 min read

Bio NC

CMP Pharma Announces That CaroSpir, the First and Only FDA-Approved Spironolactone Oral Suspension, is Now Available

CaroSpir was approved by the FDA on August 4, 2017 and is now available through normal retail distribution.

October 30, 2017

·

4 min read